论文部分内容阅读
目的:探讨米非司酮联合孕三烯酮胶囊治疗子宫肌瘤的临床效果。方法:收集我院收治的189例子宫肌瘤患者,将所有患者分为观察组和对照组,观察组100例,对照组89例。对照组患者使用常规米非司酮治疗,观察组患者使用米非司酮联合孕三烯酮胶囊的方法治疗。结果:观察组患者的治疗效果明显高于对照组患者,差异为显著性差异,(P<0.05)有统计学意义。结论:在临床对子宫肌瘤患者进行治疗的过程中,通过米非司酮联合孕三烯酮胶囊的方法对其进行治疗能够明显提升治疗效果,值得推广应用。
Objective: To investigate the clinical efficacy of mifepristone combined with gestrinone capsule in the treatment of uterine fibroids. Methods: A total of 189 cases of uterine fibroids were collected from our hospital. All patients were divided into observation group and control group, 100 cases in observation group and 89 cases in control group. The patients in the control group were treated with mifepristone, and the patients in the observation group were treated with mifepristone and gestrinone capsules. Results: The treatment effect of the observation group was significantly higher than that of the control group, the difference was significant difference (P <0.05) with statistical significance. Conclusion: During the treatment of patients with uterine fibroids, the treatment of uterine fibroids by means of mifepristone combined with gestrinone capsule can obviously improve the therapeutic effect and is worth popularizing and applying.